Back to School: How biopharma can reboot drug development. Access exclusive analysis here

BioGeneration closes Ventures Fund III at EUR82M

On Oct. 31, BioGeneration Ventures announced the final close of BioGeneration Ventures Fund III at €82 million ($95.3 million). The fund's LPs

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE